{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:05:24Z","timestamp":1790949924014,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00467-016-3437-y","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:38:43Z","timestamp":1466123923000},"page":"1315-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells"],"prefix":"10.1007","volume":"32","author":[{"given":"Agnes","family":"Hackl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Ehren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz Thorsten","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"key":"3437_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1749-6632.1993.tb17143.x","volume":"696","author":"AC Allison","year":"1993","unstructured":"Allison AC, Kowalski WJ, Muller CD, Eugui EM (1993) Mechanisms of action of mycophenolic acid. Ann N Y Acad Sci 696:63\u201387","journal-title":"Ann N Y Acad Sci"},{"key":"3437_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85\u2013118","journal-title":"Immunopharmacology"},{"key":"3437_CR3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrneph.2012.215","volume":"8","author":"BH Rovin","year":"2012","unstructured":"Rovin BH (2012) Lupus nephritis: guidelines for lupus nephritis\u2013more recommendations than data? Nat Rev Nephrol 8:620\u2013621","journal-title":"Nat Rev Nephrol"},{"key":"3437_CR4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12026-014-8609-x","volume":"60","author":"F Conti","year":"2014","unstructured":"Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G (2014) Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. Immunol Res 60:270\u2013276","journal-title":"Immunol Res"},{"key":"3437_CR5","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00467-012-2327-1","volume":"28","author":"MG Punaro","year":"2013","unstructured":"Punaro MG (2013) The treatment of systemic lupus proliferative nephritis. Pediatr Nephrol 28:2069\u20132078","journal-title":"Pediatr Nephrol"},{"key":"3437_CR6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0961203309358187","volume":"19","author":"LM Ortega","year":"2010","unstructured":"Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN (2010) Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 19:557\u2013574","journal-title":"Lupus"},{"key":"3437_CR7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.5114\/aoms.2011.26618","volume":"7","author":"D Ostalska-Nowicka","year":"2011","unstructured":"Ostalska-Nowicka D, Malinska A, Silska M, Perek B, Zachwieja J, Nowicki M (2011) Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis. Arch Med Sci D 7:1042\u20131048","journal-title":"Arch Med Sci D"},{"key":"3437_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM (2013) Kidney Disease: Improving Global outcomes. Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"3437_CR9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, T\u00f6nshoff B, Hoyer P, Querfeld U, Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie (GPN) (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689\u20131697","journal-title":"J Am Soc Nephrol"},{"key":"3437_CR10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","volume":"101","author":"N Larkins","year":"2016","unstructured":"Larkins N, Kim S, Craig J, Hodson E (2016) Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child 101:404\u2013408","journal-title":"Arch Dis Child"},{"key":"3437_CR11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/FTD.0000000000000258","volume":"38","author":"\u00c1 Hackl","year":"2016","unstructured":"Hackl \u00c1, Cseprek\u00e1l O, Gessner M, Liebau MC, Habbig S, Ehren R, M\u00fcller C, Taylan C, D\u00f6tsch J, Weber LT (2016) Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference? Ther Drug Monit 38:274\u2013279","journal-title":"Ther Drug Monit"},{"key":"3437_CR12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.ki.5002653","volume":"73","author":"V Sepe","year":"2008","unstructured":"Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A (2008) Mycophenolate mofetil in primary glomerulopathies. Kidney Int 73:154\u2013162","journal-title":"Kidney Int"},{"key":"3437_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11255-008-9454-4","volume":"41","author":"S Paydas","year":"2009","unstructured":"Paydas S, Kurt C, Taskapan H, Balal M, Sertdemir Y, Pembegul I (2009) The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis. Int Urol Nephrol 41:145\u2013152","journal-title":"Int Urol Nephrol"},{"key":"3437_CR14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2215\/CJN.07570712","volume":"8","author":"Y Chen","year":"2013","unstructured":"Chen Y, Schieppati A, Cai G, Chen X, Zamora J, Giuliano GA, Braun N, Perna A (2013) Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials. Clin J Am Soc Nephrol 8:787\u2013796","journal-title":"Clin J Am Soc Nephrol"},{"key":"3437_CR15","first-page":"CD004293","volume":"10","author":"Y Chen","year":"2014","unstructured":"Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A (2014) Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev 10:CD004293","journal-title":"Cochrane Database Syst Rev"},{"key":"3437_CR16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/phar.1575","volume":"35","author":"TH Tran","year":"2015","unstructured":"Tran TH, J Hughes G, Greenfeld C, Pham JT (2015) Overview of current and alternative therapies for idiopathic membranous nephropathy. Pharmacotherapy 35:396\u2013411","journal-title":"Pharmacotherapy"},{"key":"3437_CR17","first-page":"CD005128","volume":"8","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP). Cochrane Database Syst Rev 8:CD005128","journal-title":"Cochrane Database Syst Rev"},{"key":"3437_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00112-013-2896-5","volume":"161","author":"M Pohl","year":"2013","unstructured":"Pohl M, Dittrich K, Ehrich JHH, Hoppe B, Kemper MJ, Klaus G, Schmitt CP, Hoyer PF (2013) Behandlung der Purpura-Sch\u00f6nlein-Henoch-Nephritis bei Kindern und Jugendlichen Therapieempfehlungen der Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie (GPN). Monatsschr Kinderheilkd 161:543\u2013553","journal-title":"Monatsschr Kinderheilkd"},{"key":"3437_CR19","first-page":"CD003965","volume":"8","author":"M Vecchio","year":"2015","unstructured":"Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF (2015) Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev 8:CD003965","journal-title":"Cochrane Database Syst Rev"},{"key":"3437_CR20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2369-15-193","volume":"15","author":"Y Chen","year":"2014","unstructured":"Chen Y, Li Y, Yang S, Li Y, Liang M (2014) Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review. BMC Nephrol 15:193","journal-title":"BMC Nephrol"},{"key":"3437_CR21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ndt\/16.9.1752","volume":"16","author":"C Badid","year":"2001","unstructured":"Badid C, Desmouliere A, Laville M (2001) Mycophenolate mofetil: implications for the treatment of glomerular disease. Nephrol Dial Transplant 16:1752\u20131756","journal-title":"Nephrol Dial Transplant"},{"key":"3437_CR22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1152\/ajprenal.00209.2002","volume":"283","author":"R Zatz","year":"2002","unstructured":"Zatz R, Noronha IL, Fujihara CK (2002) Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies. Am J Physiol Renal Physiol 283:1167\u20131175","journal-title":"Am J Physiol Renal Physiol"},{"key":"3437_CR23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007890-199502270-00002","volume":"59","author":"H Azuma","year":"1995","unstructured":"Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL (1995) Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 59:460\u2013466","journal-title":"Transplantation"},{"key":"3437_CR24","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1517\/14656566.4.12.2325","volume":"4","author":"TR Srinivas","year":"2003","unstructured":"Srinivas TR, Kaplan B, Meier-Kriesche HU (2003) Mycophenolate mofetil in solid-organ transplantation. Expert Opin Pharmacother 4:2325\u20132345","journal-title":"Expert Opin Pharmacother"},{"key":"3437_CR25","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","volume":"88","author":"CE Staatz","year":"2014","unstructured":"Staatz CE, Tett SE (2014) Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol 88:1351\u20131389","journal-title":"Arch Toxicol"},{"key":"3437_CR26","unstructured":"Cohn RG, Mirkovich A, Caulfield J, Eugui EM (1999) Apoptosis of human activated peripheral T-cells and Tlymphocytic and promonocytic cell lines induced by mycophe nolic acid, the active metabolite of CellCept. In: The Sixth Basic Sciences Symposium of the Transplantation Society, Monterey, CA. p 173"},{"key":"3437_CR27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199908150-00014","volume":"68","author":"RG Cohn","year":"1996","unstructured":"Cohn RG, Mirkovich A, Dunlap B, Burton F, Chiu SH, Dugui E, Caulfield JP (1996) Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 68:411\u2013418","journal-title":"Transplantation"},{"key":"3437_CR28","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1016\/j.transproceed.2005.07.001","volume":"37","author":"E Andrikos","year":"2005","unstructured":"Andrikos E, Yavuz A, Bordoni V, Ratanarat R, De Cal M, Bonello M, Salvatori G, Levin N, Yakupoglu G, Pappas M, Ronco C (2005) Effect of cyclosporine, mycophenolate mofetil, and their combination with steroids on apoptosis in a human cultured monocytic U937 cell line. Transplant Proc 37:3226\u20133229","journal-title":"Transplant Proc"},{"key":"3437_CR29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1399-0012.2004.00222.x","volume":"12","author":"K Takahashi","year":"2004","unstructured":"Takahashi K, Reynolds M, Ogawa N, Longo DL, Burdick J (2004) Augmentation of T-cell apoptosis by immunosuppressive agents. Clin Transplant 12:72\u201375","journal-title":"Clin Transplant"},{"key":"3437_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1034\/j.1399-0012.2001.00006.x","volume":"6","author":"M Nakamura","year":"2001","unstructured":"Nakamura M, Ogawa N, Shalabi A, Maley WR, Longo D, Burdick JF (2001) Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil. Clin Transplant 6:36\u201340","journal-title":"Clin Transplant"},{"key":"3437_CR31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0041-1345(98)01984-8","volume":"31","author":"RA Blaheta","year":"1999","unstructured":"Blaheta RA, Leckel K, Wittig B, Zenker D, Oppermann E, Harder S, Scholz M, Weber S, Encke A, Markus BH (1999) Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells. Transplant Proc 31:1250\u20131252","journal-title":"Transplant Proc"},{"key":"3437_CR32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0966-3274(98)80015-4","volume":"6","author":"RA Blaheta","year":"1998","unstructured":"Blaheta RA, Leckel K, Wittig B, Zenker D, Oppermann E, Harder S, Scholz M, Weber S, Schuldes H, Encke A, Markus BH (1998) Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol 6:251\u2013259","journal-title":"Transpl Immunol"},{"key":"3437_CR33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00011-006-0070-4","volume":"55","author":"YG Wu","year":"2006","unstructured":"Wu YG, Lin H, Qian H, Zhao M, Qi XM, Wu GZ, Lin ST (2006) Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats. Inflamm Res 55:192\u2013199","journal-title":"Inflamm Res"},{"key":"3437_CR34","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.4238\/2014.April.17.11","volume":"13","author":"FQ Chen","year":"2014","unstructured":"Chen FQ, Wang QY, Wei GZ, Ma XY, Ma DW, Deng WW, Sun WB (2014) Effects of mycophenolate mofetil on the expression of monocyte chemoattractant protein-1 and fibronectin in high glucose cultured human mesangial cells. Genet Mol Res 13:3154\u20133161","journal-title":"Genet Mol Res"},{"key":"3437_CR35","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gfh302","volume":"19","author":"S Takeda","year":"2004","unstructured":"Takeda S, Takahashi M, Sado Y, Takeuchi K, Hakamata Y, Shimizu H, Kaneko T, Yamamoto H, Ito C, Ookawara S, Asano Y, Kusano E, Kobayashi E (2004) Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats. Nephrol Dial Transplant 19:2228\u20132236","journal-title":"Nephrol Dial Transplant"},{"key":"3437_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cyto.2008.06.015","volume":"44","author":"Y Wu","year":"2008","unstructured":"Wu Y, Dong J, Yuan L, Liang C, Ren K, Zhang W, Fang F, Shen J (2008) Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 44:85\u201391","journal-title":"Cytokine"},{"key":"3437_CR37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1523-1755.2003.00736.x","volume":"63","author":"R Utimura","year":"2003","unstructured":"Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R (2003) Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63:209\u2013216","journal-title":"Kidney Int"},{"key":"3437_CR38","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1046\/j.1523-1755.1998.00138.x","volume":"54","author":"CK Fujihara","year":"1998","unstructured":"Fujihara CK, Malheiros DM, Zatz R, Noronha IL (1998) Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54:1510\u20131519","journal-title":"Kidney Int"},{"key":"3437_CR39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1523-1755.1999.055003945.x","volume":"55","author":"F Romero","year":"1999","unstructured":"Romero F, Rodr\u00edguez-Iturbe B, Parra G, Gonz\u00e1lez L, Herrera-Acosta J, Tapia E (1999) Mycophenolate mofetil prevents the progressive renal failure induced by 5\/6 renal ablation in rats. Kidney Int 55:945\u2013955","journal-title":"Kidney Int"},{"key":"3437_CR40","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1681\/ASN.V1071542","volume":"10","author":"G Remuzzi","year":"1999","unstructured":"Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Benigni A (1999) Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 10:1542\u20131549","journal-title":"J Am Soc Nephrol"},{"key":"3437_CR41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/ajprenal.0197.2001","volume":"282","author":"B Rodr\u00edguez-Iturbe","year":"2002","unstructured":"Rodr\u00edguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Ch\u00e1vez M, Herrera-Acosta J, Johnson RJ, Pons HA (2002) Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282:191\u2013201","journal-title":"Am J Physiol Renal Physiol"},{"key":"3437_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000074325","volume":"95","author":"C Branden Van den","year":"2003","unstructured":"Van den Branden C, Ceyssens B, Pauwels M, Van Wichelen G, Heirman I, Jie N, Verbeelen D (2003) Effect of mycophenolate mofetil on glomerulosclerosis and renal oxidative stress in rats. Nephron Exp Nephrol 95:93\u201399","journal-title":"Nephron Exp Nephrol"},{"key":"3437_CR43","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","volume":"9","author":"MJ Penny","year":"1998","unstructured":"Penny MJ, Boyd RA, Hall BM (1998) Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. J Am Soc Nephrol 9:2272\u20132282","journal-title":"J Am Soc Nephrol"},{"key":"3437_CR44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2004.02684.x","volume":"139","author":"M Chiara","year":"2005","unstructured":"Chiara M, Menegatti E, Di Simone D, Davit A, Bellis D, Sferch D, De Rosa G, Giachino O, Sena LM, Roccatello D (2005) Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis. Clin Exp Immunol 139:225\u2013235","journal-title":"Clin Exp Immunol"},{"key":"3437_CR45","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.V9112055","volume":"9","author":"R Ziswiler","year":"1998","unstructured":"Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP (1998) Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:2055\u20132066","journal-title":"J Am Soc Nephrol"},{"key":"3437_CR46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","volume":"14","author":"IA Hauser","year":"1999","unstructured":"Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M (1999) Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 14:58\u201363","journal-title":"Nephrol Dial Transplant"},{"key":"3437_CR47","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0041-1345(98)01952-6","volume":"31","author":"W Wang","year":"1999","unstructured":"Wang W, Mo S, Chan L (1999) Mycophenolic acid inhibits PDGF-induced osteopontin expression in rat mesangial cells. Transplant Proc 31:1176\u20131177","journal-title":"Transplant Proc"},{"key":"3437_CR48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1523-1755.2002.00514.x","volume":"62","author":"I Dubus","year":"2002","unstructured":"Dubus I, Vendrely B, Christophe I, Labouyrie JP, Delmas Y, Bonnet J, Combe C (2002) Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int 62:857\u2013867","journal-title":"Kidney Int"},{"key":"3437_CR49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1523-1755.2000.00140.x","volume":"58","author":"C Badid","year":"2000","unstructured":"Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M (2000) Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 58:51\u201361","journal-title":"Kidney Int"},{"key":"3437_CR50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1152\/ajprenal.00451.2004","volume":"289","author":"F Nakhoul","year":"2005","unstructured":"Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z (2005) Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol 289:880\u2013890","journal-title":"Am J Physiol Renal Physiol"},{"key":"3437_CR51","first-page":"19781","volume":"8","author":"W Lv","year":"2015","unstructured":"Lv W, Lou J, Zhang Y, Lian P, Qi D, Wang J (2015) Mycophenolate mofetil inhibits hypertrophy and apoptosis of podocyte in vivo and in vitro. Int J Clin Exp Med 8:19781\u201319790","journal-title":"Int J Clin Exp Med"},{"key":"3437_CR52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.febslet.2006.12.051","volume":"581","author":"Y Takano","year":"2007","unstructured":"Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, Yokouchi M, Shitamura A, Yao J, Kitamura M (2007) Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K\/Akt pathway. FEBS Lett 581:421\u2013426","journal-title":"FEBS Lett"},{"key":"3437_CR53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000354600","volume":"92","author":"W Lv","year":"2013","unstructured":"Lv W, Zhang Y, Guan G, Li P, Wang J, Qi D (2013) Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats. Pharmacology 92:227\u2013234","journal-title":"Pharmacology"},{"key":"3437_CR54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei C, M\u00f6ller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55\u201363","journal-title":"Nat Med"},{"key":"3437_CR55","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0961203313480398","volume":"22","author":"CC Cheng","year":"2013","unstructured":"Cheng CC, Lee YF, Lan JL, Wu MJ, Hsieh TY, Lin NN, Wang JM, Chiu YT (2013) Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model. Lupus 22:554\u2013561","journal-title":"Lupus"},{"key":"3437_CR56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/eci.12191","volume":"44","author":"W Olejarz","year":"2014","unstructured":"Olejarz W, Bryk D, Zapolska-Downar D, Ma\u0142ecki M, Stachurska A, Sitkiewicz D (2014) Mycophenolic acid attenuates the tumour necrosis factor-\u03b1-mediated proinflammatory response in endothelial cells by blocking the MAPK\/NF-kB and ROS pathways. Eur J Clin Invest 44:54\u201364","journal-title":"Eur J Clin Invest"},{"key":"3437_CR57","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.intimp.2005.01.015","volume":"5","author":"Y Huang","year":"2005","unstructured":"Huang Y, Liu Z, Huang H, Liu H, Li L (2005) Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol 5:1029\u20131039","journal-title":"Int Immunopharmacol"},{"key":"3437_CR58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/CCLM.1999.045","volume":"37","author":"P Bertalanffy","year":"1999","unstructured":"Bertalanffy P, Dubsky P, Wolner E, Weigel G (1999) Alterations of endothelial nucleotide levels by mycophenolic acid result in changes of membrane glycosylation and E-selectin expression. Clin Chem Lab Med 37:259\u2013264","journal-title":"Clin Chem Lab Med"},{"key":"3437_CR59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-8981(01)00527-7","volume":"310","author":"M Raab","year":"2001","unstructured":"Raab M, Daxecker H, Karimi A, Markovic S, Cichna M, Markl P, M\u00fcller MM (2001) In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clin Chim Acta 310:89\u201398","journal-title":"Clin Chim Acta"},{"key":"3437_CR60","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjp.0701517","volume":"122","author":"IA Hauser","year":"1997","unstructured":"Hauser IA, Johnson DR, Th\u00e9venod F, Goppelt-Str\u00fcbe M (1997) Effect of mycophenolic acid on TNF alpha-induced expression of cell adhesion molecules in human venous endothelial cells in vitro. Br J Pharmacol 122:1315\u20131322","journal-title":"Br J Pharmacol"},{"key":"3437_CR61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/CCLM.1999.044","volume":"37","author":"G Weigel","year":"1999","unstructured":"Weigel G, Bertalanffy P, Dubsky P, Griesmacher A, Wolner E (1999) Mycophenolic acid influences T helper 2 (Th2) cytokine induced expression of intercellular cell adhesion molecule-1 (ICAM-1) on human endothelial cells. Clin Chem Lab Med 37:253\u2013257","journal-title":"Clin Chem Lab Med"},{"key":"3437_CR62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/mol.62.3.453","volume":"62","author":"G Weigel","year":"2002","unstructured":"Weigel G, Bertalanffy P, Wolner E (2002) Depletion of intracellular GTP results in nuclear factor-kappaB activation and intercellular adhesion molecule-1 expression in human endothelial cells. Mol Pharmacol 62:453\u2013462","journal-title":"Mol Pharmacol"},{"key":"3437_CR63","doi-asserted-by":"crossref","first-page":"76S","DOI":"10.1042\/CS103S076S","volume":"48","author":"C Haug","year":"2002","unstructured":"Haug C, Schmid-Kotsas A, Linder T, Jehle PM, Bachem MG, Gruenert A, Rozdzinski E (2002) The immunosuppressive drug mycophenolic acid reduces endothelin-1 synthesis in endothelial cells and renal epithelial cells. Clin Sci 48:76S\u201380S","journal-title":"Clin Sci"},{"key":"3437_CR64","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s11033-009-9599-y","volume":"37","author":"H Shui","year":"2010","unstructured":"Shui H, Gao P, Si X, Ding G (2010) Mycophenolic acid inhibits albumin-induced MCP-1 expression in renal tubular epithelial cells through the p38 MAPK pathway. Mol Biol Rep 37:1749\u20131754","journal-title":"Mol Biol Rep"},{"key":"3437_CR65","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.tp.0000255680.71816.aa","volume":"83","author":"JW Copeland","year":"2007","unstructured":"Copeland JW, Beaumont BW, Merrilees MJ, Pilmore HL (2007) Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 83:809\u2013814","journal-title":"Transplantation"},{"key":"3437_CR66","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.3892\/mmr.2015.3934","volume":"12","author":"X Xiao","year":"2015","unstructured":"Xiao X, Wang J, Chang X, Zhen J, Zhou G, Hu Z (2015) Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats. Mol Med Rep 12:4043\u20134050","journal-title":"Mol Med Rep"},{"key":"3437_CR67","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2001.00737.x","volume":"59","author":"B Rodr\u00edguez-Iturbe","year":"2001","unstructured":"Rodr\u00edguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rinc\u00f3n J, Ch\u00e1vez M, Parra G, Herrera-Acosta J, G\u00f3mez-Garre D, Largo R, Egido J, Johnson RJ (2001) Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59:2222\u20132232","journal-title":"Kidney Int"},{"key":"3437_CR68","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1681\/ASN.V1291937","volume":"12","author":"M Noris","year":"2001","unstructured":"Noris M, Azzollini N, Pezzotta A, Mister M, Benigni A, Marchetti G, Gagliardini E, Perico N, Remuzzi G (2001) Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. J Am Soc Nephrol 12:1937\u20131946","journal-title":"J Am Soc Nephrol"},{"key":"3437_CR69","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/ajprenal.00442.2004","volume":"289","author":"S Kr\u00e4mer","year":"2005","unstructured":"Kr\u00e4mer S, Loof T, Martini S, R\u00fcckert M, Wang Y, B\u00f6hler T, Shimizu F, Kawachi H, Neumayer HH, Peters H (2005) Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. Am J Physiol Renal Physiol 289:359\u2013368","journal-title":"Am J Physiol Renal Physiol"},{"key":"3437_CR70","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1046\/j.1523-1755.2003.00811.x","volume":"63","author":"E Tapia","year":"2003","unstructured":"Tapia E, Franco M, S\u00e1nchez-Lozada LG, Soto V, Avila-Casado C, Santamar\u00eda J, Quiroz Y, Rodr\u00edguez-Iturbe B, Herrera-Acosta J (2003) Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int 63:994\u20131002","journal-title":"Kidney Int"},{"key":"3437_CR71","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1111\/j.1523-1755.2005.00662.x","volume":"68","author":"B Yang","year":"2005","unstructured":"Yang B, Jain S, Pawluczyk IZ, Imtiaz S, Bowley L, Ashra SY, Nicholson L (2005) Inflammation and caspase activation in long-term renal ischemia\/reperfusion injury and immunosuppression in rats. Kidney Int 68:2050\u20132067","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3437-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3437-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T21:05:30Z","timestamp":1656709530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3437-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3437"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3437-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}